Dingxin Capital
VC Fund
Shenzhen, China
Dingxin Capital is an investment management agency that specializes in equity investments. The partners are mainly from domestic first-line investment institutions such as CDH, Jiuding and Zhongjin. They have deep accumulation and rich experience in the equity investment field, paying attention to the construction of the whole organization andtrying to build a truly sustainable competition. Investment institutions.
- Total investments:
- 47
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Dingxin Capital invests in
Stages Dingxin Capital invests in
Countries Dingxin Capital invests in
Contacts
1 more contact available
Investment Focus
Industry
- Manufacturing 13 (28%)
- Medical 10 (21%)
- Semiconductor 10 (21%)
- Health Care 7 (15%)
- Medical Device 7 (15%)
Stage
- Series A 11 (23%)
- Seed 10 (21%)
- Funding Round 7 (15%)
- Series B 5 (11%)
- Venture - Series Unknown 5 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Deng Ning
Partner
|
Partner | Total investments: 4 | Find email | |
|
Hu Hui
Founding partner
|
Founding partner | Total investments: 2 | Find email | |
Yu Kang
Senior Investment Manager
|
Senior Investment Manager | Total investments: 0 | Find email | |
|
Zhou Zhou
Senior Partner
|
Senior Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Light Year Exploration
|
Light Year Exploration is a distributor of vehicle mechanical products. | Seed / Aug 03, 2026 | |
Xingyuan Zongheng Network Technology
|
Beijing Xingyuan Zongheng Network Technology is an aerospace and satellite internet enterprise. The company focuses on high-tech satellite system development, constellation networking, and commercial operations. | $14.8M / Angel / Jul 17, 2026 | |
Xingaotopi
|
Xingaotopi focuses on the innovative development of novel therapeutic drugs for sensorineural hearing loss, aiming to restore auditory function and improve quality of life through advanced biomedical research and cutting-edge treatment technologies. | $14.3M / Seed / Jan 04, 2026 | |
Novlead Biotech
|
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations. | Series C / Apr 15, 2025 | |
Fine Vision
|
Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition. | Series A / Jan 16, 2025 | |
Jike Optoelectronics
|
Jike Optoelectronics is an R&D and production firm for optical components, and they employ a special micro-nano processing technique to make side surface waveguides incredibly smooth. | $13.8M / Series A / Jun 26, 2024 | |
Zhihe Biotechnology
|
Zhihe Bio is a synthetic biology manufacturer of oleochemicals. | $1.4M / Seed / May 20, 2024 | |
Reju Therapeutics
|
Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions. | Seed / May 08, 2024 | |
Ruining Bio
|
Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine. | $8.5M / Series B / Jan 24, 2024 | |
Legendsemi
|
Legendsemi focuses on the development and design of high-performance analog and mixed-signal chips. | $13.9M / Series A / Jun 21, 2023 | |
| See all 47 investments → | |||
Co-Investors
Prox Ventures
3 deals together
CAS Star
2 deals together
Grit Ventures
2 deals together
Lilly Asia Ventures
2 deals together
Longpan Investment
2 deals together
Nanjing Innovation Capital Group
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Dingxin Capital invest in?
Dingxin Capital invests primarily in Manufacturing, Medical and Semiconductor startups, most often at Series A and Seed stage. Most of the 47 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dingxin Capital?
Public channels for Dingxin Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Dingxin Capital?
The team at Dingxin Capital includes Deng Ning (Partner), Hu Hui (Founding partner) and Yu Kang (Senior Investment Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
